The influence of a/fentanil on induction and recovery characteristics of propofol was examined in women presenting as day cases for minor gynaecological surgery. A/fentanil reduced the incidence of pain on injection and the induction and maintenance requirements of propofol. This was at the expense of more prolonged apnoea. Immediate recovery characteristics were similar in each group although changes in Critical Flicker Fusion Threshold as a measure of psychomotor impairment were more pronounced after a/fentanil. Such differences were insignificant at three hours by which time Critical Flicker Fusion Threshold had returned to baseline and patients were ready for discharge home.
Propofol has a well established place in anaesthesia for short surgical procedures both as an induction agent and increasingly for maintenance of anaesthesia. I Its induction characteristics compare favourably with other agents, the main disadvantages being pain on injection, apnoea and dose-related hypotension. Alfentanil has a short duration of action and has been used with propofol by bolus injection or as a continuous infusion. 2 The specific action of each drug, i.e. hypnosis and analgesia respectively, is potentiated when they are used together. 3 The aim of the study was to investigate the effects of alfentanil on the induction characteristics of propofol for short gynaecological procedures and to look at the implications for recovery. Critical Flicker Fusion Threshold (CFFT) was used as a measure of psychomotor recovery. This is one component of the Leeds psychomotor test which has not been used in recovery studies conducted in Australasia.
METHODS
The study had local ethical committee approval. It was divided into two parts: the first part looked at the effects of alfentanil on the induction characteristics of propofol. The patients gave informed consent and those taking hypnotic drugs were excluded from the study. Unpremedicated patients (ASA 1 or 2) presenting as outpatients for short gynaecological procedures were randomly assigned to two groups: Group 1 received propofol alone, Group 2 received in addition 10 Ilg/kg alfentanil intravenously two minutes before induction. The induction dose of propofol was calculated as 2.5 mg/kg body weight. Half of this dose was given over 20-30 seconds (through an IS-gauge cannula inserted in the dorsum of the hand) and further increments of 10 mg were given every fifteen seconds until loss of eyelash reflex. This became the induction dose. Induction characteristics were graded as satisfactory or unsatisfactory by the same anaesthetist according to a scale devised by Dundee et al., 4 with reference to pain on injection, spontaneous muscle movements, tremor and rigidity. The duration of apnoea was also noted and if prolonged beyond 30-60 seconds, ventilation was assisted until the return of spontaneous respiration. Further increments of propofol 20 mg were titrated against changes in respiration and reflex movement and anaesthesia was maintained with nitrous oxide and oxygen 2: I through a Bain system. The second part of the study concentrated on aspects of recovery. The same two groups were used as in the first part, i.e. patients received propofol alone or an additional preinduction dose of alfentanil (10 l1g1kg). Before arriving in theatre, they were familiarised with the Flicker Fusion apparatus. An average of three measurements provided the baseline CFFT. This time, at induction, two-thirds of the calculated dose ofpropofol was given over twenty seconds and further increments every five to ten seconds until loss of consciousness. Blood pressure and pulse rate were recorded every minute by a Datascope Accutor lA. At the end of the procedure patients were transferred to the recovery area where a second anaesthetist assessed immediate recovery characteristics. CFFT testing was performed at half-hourly intervals for three hours to determine psychomotor recovery.
RESULTS
The results of the first part of the study are given in Table 1 . Age, weight and height were comparable in the two groups, but the induction dose of propofol was significantly less in Group 2 (alfentanil pre-induction). The second part confirmed the above findings (Table 2) . Patient characteristics were again comparable and there was a significant reduction in both the induction and maintenance dose of propofol in the alfentanil group.
The data was combined for the purpose of analysis and the results are given in Table 3 . Pre-treatment with alfentanil reduced both the mild and severe pain experienced on injection of propofol (P = 0.007 and 0.008 respectively). Prolonged apnoea (more than 60 seconds) occurred more frequently in this group (P = 0.002). Grade of induction was During the second part of the study, when anaesthesia was maintained with increments of propofol alone, one-minute recordings of blood pressure and heart rate demonstrated cardiovascular stability in both groups. Blood pressure remained within 40 mmHg of initial recording with two exceptions in the alfentanil group, and heart rate deviated less than 40 beats per minute except for one patient in the same group. Minor falls in blood pressure (20-40 mmHg) were more frequent in Group 2 (P = 0.00003) although changes in heart rate were evenly distributed between the two grOUDS.
The immediate recovery characteristics are shown in Table 4 . They were similar in each group and most patients were orientated and answering questions ten minutes into recovery. Changes in Critical Flicker Fusion Threshold are represented in Figure 1 CFFT was significantly impaired in both groups at 60, 90 and 120 minutes, but returned to baseline value at 180 minutes. The deviation was more pronounced in Group 2 (receiving alfentanil) over the period of the study. The Pvalues at these times are included in Figure 1 . Only one patient from each group experienced nausea in the three-hour recovery period.
DISCUSSION
Once again, propofol provided adequate conditions for minor surgery when combined with nitrous oxide and oxygen, maintaining cardiovascular stability and allowing rapid return of protective reflexes at the end of the procedure. Propofollacks a specific analgesic action although in contrast to barbiturates the analgesic threshold is not actually lowered. 5 The addition of an opioid satisfies the requirement for balanced anaesthesia and alfentanil seems a logical choice for short surgical procedures because of its rapid onset and short duration of action. Alfentanil reaches its peak effect within 90 to 120 seconds of intravenous injection, four times faster than fentanyl. Central nervous system penetration is faster because more of the drug is present in its diffusable, nonionised fraction at body pH, and the central compartment for alfentanil is smaller, generating a larger concentration gradient between blood and CSF. A single bolus dose undergoes rapid redistribution terminating the action of small doses. High protein binding and lower lipid solubility limit its penetration of fat and muscle reducing its steady-state volume of distribution and contributing to its short elimination half-life, i.e. 90 minutes compared with 200 minutes for fentanyl.6 Propofol is highly lipid-soluble, enhancing penetration of the blood-brain barrier and onset of anaesthesia. It is rapidly redistributed and eliminated from the body by hepatic metabolism to non-active metabolites. Other tissues contribute as total body clearance exceeds hepatic blood flow. 5 Studies have been reluctant to acknowledge any benefits of propofol/opioid combinations for short relatively painless surgical procedures. 7
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The addition of fentanyl, despite reducing induction time and total dose of propofol, had no useful effect on the quality of induction or maintenance of anaesthesia and the more recent study showed no dose reduction after alfentanil 5 Ilglkg. We used alfentanil 10 Ilglkg and felt it was of benefit, reducing the pain on injection and significantly reducing propofol dose requirements. Patients receiving alfentanil were more prone to develop apnoea, but as noted in earlier studies they tolerated short periods of manual ventilation without compromising the safety of the anaesthetic. 9
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Minor falls in blood pressure also occurred more frequently after the combined use of alfentanil and propofol.
Pain on injection was experienced in 40% of the group receiving propofol alone, which is higher than the reported incidence of 30%. 8 Alfentanil pretreatment reduced both mild and severe pain caused by propofol. The addition of lignocaine 1-2 ml to the propofol or its prior intravenous injection has also been used to attenuate pain. 8 . 11 Nausea and vomiting occurs infrequently after propofol anaesthesia and again in this study only one patient in each group experienced nausea postoperatively. Others have alluded to an antiemetic effect of propofol and found that addition of an opioid -fentanyl, or alfentanil -did not increase the incidence of nausea and vomiting.I.12.13 This contrasts with an incidence of 54% in patients receiving alfentanil and methohexitone for day-case gynaecological procedures although svntocinon may have contributed.
A wide variety of tests have been used to assess recovery from anaesthesia. These may be subdivided into clinical tests of orientation and co-ordination, paper and pencil tests and psychomotor tests. They correlate with various aspects of recovery, e.g. fitness for discharge home, street fitness and fitness for more complex tasks such as driving and use of machinery. The Leeds Psychomotor tester measures two parameters -Critical Flicker Fusion Threshold (CFFT) and Choice Reaction Time (CRT). It was originally designed to investigate the effects of psychoactive drugs on CNS arousal and psychomotor performance but has been used increasingly in recovery studies. A less elaborate version -the Flicker Fusion tester -measures only CFFT and comprises a set of four light-emitting diodes held about one metre in front of the subject. These lights are made to flicker at increasing frequencies (from 10 to 40 Hz) and decreasing frequencies (50 to 10Hz) to provide an average measure of fusion frequency, i.e. the point at which the lights appear to stop flickering. Recovery studies involving the Leeds Psychomotor tester show similar trends in both CR T and CFFT, 10 justifying the use of CFFT as a single measure of psychomotor recovery in this study.
We found that the fall in CFFT from baseline did not occur until 60 minutes into recovery in contrast to earlier studies which had shown a decline at 30 minutes. 10 Patients often experience a definite sense of well-being after propofol anaesthesia and McDonald et al. have postulated a specific action on mood centres. IS This arousal and initial euphoria may have contributed to the preservation of CFFT at 30 minutes in our study, an effect which had perhaps been masked by the use of volatile agents in the study by MacKenzie and Grant. lo CFFT was depressed for up to three hours into the recovery period, emphasising again the subtle residual effects of supposedly short-acting agents. A single dose of alfentanil lead to greater impairment of CFFT over the three-hour period despite the use of a lower total doses of propofol. However, at three hours such differences were minimal and statistically insignificant.
